Jan 8, 2026
How do de‑identification and redaction practices affect independent reanalysis of clinical trial participant‑level data?
De‑identification and redaction are double‑edged tools: they reduce re‑identification risk but can materially impair independent reanalysis by removing, suppressing, or perturbing the very variables a...